Researchers successfully use CRISPR-Cpf1 to correct Duchenne muscular dystrophy in both animal and human cells.
A new study may help to increase understanding of Duchenne muscular dystrophy.
The FDA have approved the first drug designed to treat patients with Duchenne muscular dystrophy.
Muscle regeneration in mouse models of Duchenne muscular dystrophy is improved when THI is purified and given in appropriate doses, a new study suggests.
Researchers have been able to repair a defect responsible for Duchenne muscular dystrophy by using a novel genetic editing technique.
A nationwide clinical trial for a new type treatment that could offer help to those suffering from Duchenne Muscular Dystrophy, a devastating neuromuscular disease.
Scientists identified a sequence in the dystrophin gene that is essential for helping muscle tissues function, a breakthrough discovery that could lead to treatments for the deadly hereditary disease.
RTC 13 effectively counteracts ‘nonsense’ mutation that causes disorder. Scientists at UCLA have identified a new compound that could treat...
Researchers from the University of Minnesota’s Lillehei Heart Institute have effectively treated muscular dystrophy in mice using human stem cells...
